Osteoanabolics
Osteoporosis is characterized by reduced bone mass, impaired bone quality, and a propensity to fracture. An "osteoanabolic" should be referred to any therapy that helps increase bone mass. Bone mass represents 80% of bone mechanical strength. A low bone mass therefore provides the stronges...
Main Authors: | Vishal Gupta, Mitul Abhaykumar Shah, Sagar Kirtibhai Shah, Jinen Mukeshbhai Shah |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2012-01-01
|
Series: | Indian Journal of Endocrinology and Metabolism |
Subjects: | |
Online Access: | http://www.ijem.in/article.asp?issn=2230-8210;year=2012;volume=16;issue=3;spage=349;epage=357;aulast=Gupta |
Similar Items
-
Review of Current Real-World Experience with Teriparatide as Treatment of Osteoporosis in Different Patient Groups
by: Barbara Hauser, et al.
Published: (2021-04-01) -
Abaloparatide exhibits greater osteoanabolic response and higher cAMP stimulation and β‐arrestin recruitment than teriparatide
by: Karim Sahbani, et al.
Published: (2019-10-01) -
Abaloparatide and the Spine: A Narrative Review
by: Thompson JC, et al.
Published: (2020-06-01) -
Effects of Extracellular Osteoanabolic Agents on the Endogenous Response of Osteoblastic Cells
by: Giulia Alloisio, et al.
Published: (2021-09-01) -
A new contralateral atypical femoral fracture despite sequential therapy with teriparatide and strontium ranelate
by: Hanh H Nguyen, et al.
Published: (2017-06-01)